16.05.2018     09:00–20:00

Self study ePoster

Self Study ePoster


Self study ePoster

Self Study ePoster

P 12 14 years fever-range whole body hyperthermia in adjuvant recurrence prophylaxis of breast cancer
Stephan Wey (Lauf/DE)

P 13 Secondary and tertiary recurrence prevention with fever range whole-body hyperthermia in (metastatic) malignant melanoma
Stephan Wey (Lauf/DE)

P 15 Clonogenic survival as well as motility of malignant cells is reduced by hyperthermia alone or in combination with irradiation
Hüseyin Sahinbas (Bochum/DE), Helmut Bühler (Bochum/DE)

P 16 In vitro and vivo temperature measurements invasively and minimal invasively in capacitative hyperthermia at 13,56 Mhz
Hüseyin Sahinbas (Bochum/DE)

P 17 The Moscow-Berlin hyperthermia treatment planning system
Dennis Sullivan (Mosow, Idaho/US)

P 18  The agarose cup – – A new tool for ex vivo cultivation of skin microbiopsies to assess effects of hyperthermia
Andreas R. Thomsen (Freiburg, Heidelberg/DE)

P 19 Relationship between energy dosage and apoptotic cell death by modulated electro-hyperthermia
Samuel Yushan Wang (Taipei/TW)

P 20 Immunogenic cell death during maintenance chemotherapy and subsequent multimodal immunotherapy for GBM
Stefaan van Gool (Köln/DE)

P 21 Feasibility of tumor vasculature targeting – comparative study of different cationic and anionic thermosensitive liposomes
Matteo Petrini (Munich/DE)

P 22 Identification of suitable electromagnetic and thermal models for patient specific hyperthermia planning for SIGMA30 applicator using direct temperature measurements
Jacek Nadobny (Berlin/DE)

P 24 Establishing selected foundations of hyperthermic oncology
Georg Westerkamp (Hamburg/DE)

P 25 Modulated electro-hyperthermia in pancreatic cancer patients – initial experience and clinicopathologic evaluation
A. Marcell Szasz (Budapest/HU)

P 26 Clinical studies of oncothermia
Andras Szasz (Budaors/HU)

P 27  Modulated electro-hyperthermia treatment of pancreas ductal adenocarcinoma in vitro
Gertrud Forika (Budapest/HU)

P 28 New possibilities for magnetic hyperthermia – design of cluster topology to improve heating power
Gerardo Goya (Zaragoza/ES)

P 29 Definitive outcome of  hyperthermia-radiotherapy association for superficial recurrent tumors
Gabriella Cattari (Candiolo/IT)

P 30 Pitfalls in acoustic transducer modeling for focused ultrasound (FUS)
Redi Poni (Zurich/CH)

P 31 Optimalization of microwave hyperthermia waveguide applicator for head and neck region
Ondrej Fiser (Kladno/CZ)

P 32 Regional deep hyperthermia – comparison of intratumoral invasive thermometry and thermal numeric simulations in patients
Bassim Aklan (Munich/DE)

P 33 Implementation of a new MRI-hyperthermia-hybridsystem into clinical routine
Bassim Aklan (Munich/DE)

P 34 Extracting information about cellular repair processes after hyperthermia – radiotherapy by model-based data analysis – ambiguities in survival prediction as a challenge?
Mathias S. Weyland (Winterthur/CH)

P 35 Exogenous and endogenous hyperthermia combining low-dose checkpoint inhibitors with interleukin-2 (IL-2) and fever range whole body and local regional hyperthermia in stage IV cancer
Ralf Kleef (Vienna/AT)

P 36 Do SAR quality indicators predict temperature? A verification study in head and neck hyperthermia
Gennaro G. Bellizzi (Reggio Calabria, Napoli/IT)

P 37 Thermoresponsive and light-to-heat converting nanogels for biomedical applications
Stefanie Wedepohl (Berlin/DE)

P 38 Fever-range Whole Body Hyperthermia with concomitant Capecitabine in third line therapy for BRCA mutated metastatic breast cancer
João Pinto (Lisboa/PT)

P 39 Oncologic deep local Hyperthermia in advanced cancer patients. Feasibility study
Joan Vidal-Jove (Barcelona/ES)

P 40 Review: Whole-Body-Thermochemotherapy: A Treatment passing into silence?
Alexander Herzog (Bad Salzhausen/DE)

P 41 Hyperthermic intravesical chemotherapy for BCG-unresponsive non-muscle invasive bladder cancer
Joost L. Boormans (Rotterdam/NL)

P 42 Hyperthermic temperatures in body coil bird cage of 3.0 T in pigs
Chie-Hee Cho (Berlin/DE)